Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #7373
Reference
MSAN(2021)22
Name
Locorten Vioform® (flumetasone/clioquinol) 0.02% w/v / 1% w/v ear drops solution
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
SUPPLIES
Description
1. Locorten Vioform® (flumetasone/clioquinol) 0.02% w/v / 1% w/v ear drops are out of stock until April 2022.
2. There are no other combination products on market that contain a steroid and an antimicrobial agent with both antibacterial and antifungal properties.
3. Alternative topical combination steroid and antibacterial preparations for the ear are available.
4. The only topical antifungal preparation on the market for use in the ear is Canesten® (clotrimazole) 1% solution.
2. There are no other combination products on market that contain a steroid and an antimicrobial agent with both antibacterial and antifungal properties.
3. Alternative topical combination steroid and antibacterial preparations for the ear are available.
4. The only topical antifungal preparation on the market for use in the ear is Canesten® (clotrimazole) 1% solution.
Contact Name
Contact Email
Contact Address
Created
2021-08-03 00:00:00
Click to go back to homepage